Mandala Justin, Muyumbu Linda, Austin Gwyneth, Ashiono Everline, Stankevitz Kayla, Bateganya Moses, Chabikuli Otto
HIV Department, FHI 360, Washington DC, United States of America.
Department of Strategic Information, FHI 360, Nairobi, Kenya.
J Public Health Afr. 2024 Oct 10;15(1):626. doi: 10.4102/jphia.v15i1.626. eCollection 2024.
In 205 health facilities, mother-to-child transmission (MTCT) of human immunodeficiency virus (HIV) rates were reduced from 7.4% to 2.1% between 2017 and 2020, respectively.
To determine characteristics that potentially correlate to the change in MTCT rates between two time points.
Study was conducted in Kenya, semi-urban and rural areas.
A retrospective, cross-sectional, exploratory analysis of programme implementation at two points in time (2017 and 2020). Between 2017 and 2020, we compared over 170 mother-infant pairs where MTCT occurred to over 6000 mother-infant pairs where MTCT did not occur through the following factors: (1) location of health facilities, (2) mother and infant characteristics, (3) access to antiretroviral therapy (ART), and (4) viral load suppression. Bivariate and multivariable logistic regression models were used to identify factors associated with MTCT.
Factors significantly associated with reduced MTCT rates were time points, mother's age, infant age at first test, proportions of mothers receiving ART, and maternal viral load. When restricting the analysis to the sub-counties contributing data at both time points, the results were similar; however, counties' location became significant in the updated model, as did the interaction term for mother and infant receipt of antiretrovirals (odds ratio [OR]: 0.228; = 0.04).
What changed between 2017 and 2020 is a higher proportion of pregnant women living with HIV received ART. Also, unlike in 2017, in 2020, tenofovir disoproxil fumarate was the backbone of the ART regimen for the prevention of MTCT.
The findings can potentially inform efforts on elimination of mother-to-child transmission of HIV.
在205家医疗机构中,2017年至2020年间,人类免疫缺陷病毒(HIV)的母婴传播(MTCT)率分别从7.4%降至2.1%。
确定与两个时间点之间MTCT率变化潜在相关的特征。
研究在肯尼亚的半城市和农村地区进行。
对两个时间点(2017年和2020年)的项目实施情况进行回顾性、横断面、探索性分析。在2017年至2020年期间,我们通过以下因素比较了170多对发生MTCT的母婴对和6000多对未发生MTCT的母婴对:(1)医疗机构的位置,(2)母亲和婴儿的特征,(3)获得抗逆转录病毒疗法(ART)的情况,以及(4)病毒载量抑制情况。使用双变量和多变量逻辑回归模型来确定与MTCT相关的因素。
与MTCT率降低显著相关的因素是时间点、母亲年龄、首次检测时的婴儿年龄、接受ART的母亲比例以及母亲的病毒载量。当将分析限制在两个时间点都提供数据的子县时,结果相似;然而,在更新后的模型中,县的位置变得显著,母亲和婴儿接受抗逆转录病毒药物的交互项也变得显著(优势比[OR]:0.228;P = 0.04)。
2017年至2020年间发生变化的是感染HIV的孕妇接受ART的比例更高。此外,与2017年不同的是,2020年,替诺福韦酯是预防MTCT的ART方案的主要药物。
这些发现可能为消除HIV母婴传播的努力提供参考。